We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ACHV

Price
3.35
Stock movement up
+0.21 (6.69%)
Company name
Achieve Life Sciences Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
171.20M
Ent value
178.20M
Price/Sales
-
Price/Book
5.46
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-53.91%
1 year return
-32.73%
3 year return
-17.97%
5 year return
-16.95%
10 year return
-52.78%
Last updated: 2025-08-27

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

ACHV does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book5.46
EV to Sales-

FINANCIALS

Per share

Loading...
Per share data
Current share count51.10M
EPS (TTM)-0.96
FCF per share (TTM)-0.73

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)-171.00K
Operating income (TTM)-31.34M
Net income (TTM)-32.94M
EPS (TTM)-0.96
EPS (1y forward)-0.70

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash9.54M
Net receivables0.00
Total current assets45.53M
Goodwill1.03M
Intangible assets0.00
Property, plant and equipment0.00
Total assets47.92M
Accounts payable1.01M
Short/Current long term debt9.85M
Total current liabilities6.72M
Total liabilities16.54M
Shareholder's equity31.38M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-24.95M
Capital expenditures (TTM)6.00K
Free cash flow (TTM)-24.95M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-104.99%
Return on Assets-68.75%
Return on Invested Capital-104.91%
Cash Return on Invested Capital-79.46%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open3.16
Daily high3.41
Daily low3.06
Daily Volume442K
All-time high1821600.00
1y analyst estimate15.50
Beta1.31
EPS (TTM)-0.96
Dividend per share-
Ex-div date-
Next earnings date6 Nov 2025

Downside potential

Loading...
Downside potential data
ACHVS&P500
Current price drop from All-time high-100.00%-3.04%
Highest price drop-100.00%-56.47%
Date of highest drop15 May 20259 Mar 2009
Avg drop from high-89.13%-11.04%
Avg time to new high100 days12 days
Max time to new high6965 days1805 days
COMPANY DETAILS
ACHV (Achieve Life Sciences Inc) company logo
Marketcap
171.20M
Marketcap category
Small-cap
Description
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Employees
25
Investor relations
-
SEC filings
CEO
Richard Alistair Balfour Stewart
Country
USA
City
Vancouver
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...